Optiscan Imaging Ltd (OIL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Optiscan Imaging Ltd (OIL) has a cash flow conversion efficiency ratio of -0.188x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.13 Million ≈ $-2.92 Million USD) by net assets (AU$22.02 Million ≈ $15.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OIL days of operational coverage to measure how many days the company can operate on defensive assets alone.
Optiscan Imaging Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Optiscan Imaging Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Optiscan Imaging Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Optiscan Imaging Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Negri Sembilan Oil Palms Bhd
KLSE:2038
|
0.080x |
|
11 bit studios S.A
WAR:11B
|
0.109x |
|
Berjaya Food Bhd
KLSE:5196
|
-0.045x |
|
Insumos Agroquimicos SA
BA:INAG
|
-1.082x |
|
Rallybio Corp
NASDAQ:RLYB
|
-0.159x |
|
Charlton Aria Acquisition Corporation Class A Ordinary Shares
NASDAQ:CHAR
|
-0.001x |
|
Dhunseri Ventures Limited
NSE:DVL
|
-0.046x |
|
Kabra Extrusion Technik Limited
NSE:KABRAEXTRU
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Optiscan Imaging Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Optiscan Imaging Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Optiscan Imaging Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$7.71 Million ≈ $5.46 Million |
AU$-6.21 Million ≈ $-4.40 Million |
-0.806x | -94.45% |
| 2024-06-30 | AU$13.87 Million ≈ $9.81 Million |
AU$-5.74 Million ≈ $-4.06 Million |
-0.414x | +60.00% |
| 2023-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-3.15 Million ≈ $-2.23 Million |
-1.035x | -78.07% |
| 2022-06-30 | AU$6.59 Million ≈ $4.66 Million |
AU$-3.83 Million ≈ $-2.71 Million |
-0.582x | -179.42% |
| 2021-06-30 | AU$10.22 Million ≈ $7.23 Million |
AU$-2.13 Million ≈ $-1.50 Million |
-0.208x | +76.93% |
| 2020-06-30 | AU$1.55 Million ≈ $1.10 Million |
AU$-1.40 Million ≈ $-988.16K |
-0.902x | -79.27% |
| 2019-06-30 | AU$2.82 Million ≈ $2.00 Million |
AU$-1.42 Million ≈ $-1.01 Million |
-0.503x | +30.68% |
| 2018-06-30 | AU$3.20 Million ≈ $2.27 Million |
AU$-2.32 Million ≈ $-1.64 Million |
-0.726x | +64.58% |
| 2017-06-30 | AU$1.67 Million ≈ $1.18 Million |
AU$-3.41 Million ≈ $-2.41 Million |
-2.049x | -401.67% |
| 2016-06-30 | AU$-749.65K ≈ $-530.43K |
AU$-509.25K ≈ $-360.32K |
0.679x | -91.85% |
| 2015-06-30 | AU$-175.21K ≈ $-123.97K |
AU$-1.46 Million ≈ $-1.03 Million |
8.331x | +125.11% |
| 2014-06-30 | AU$-184.66K ≈ $-130.66K |
AU$-683.39K ≈ $-483.54K |
3.701x | +395.39% |
| 2013-06-30 | AU$952.46K ≈ $673.92K |
AU$-1.19 Million ≈ $-844.31K |
-1.253x | +50.54% |
| 2012-06-30 | AU$313.31K ≈ $221.69K |
AU$-793.54K ≈ $-561.48K |
-2.533x | -625.77% |
| 2011-06-30 | AU$1.34 Million ≈ $950.06K |
AU$-468.58K ≈ $-331.55K |
-0.349x | +63.04% |
| 2010-06-30 | AU$1.30 Million ≈ $920.02K |
AU$-1.23 Million ≈ $-868.79K |
-0.944x | +47.97% |
| 2009-06-30 | AU$1.76 Million ≈ $1.24 Million |
AU$-3.19 Million ≈ $-2.26 Million |
-1.815x | -241.43% |
| 2008-06-30 | AU$7.70 Million ≈ $5.45 Million |
AU$-4.09 Million ≈ $-2.90 Million |
-0.532x | -180.52% |
| 2007-06-30 | AU$9.93 Million ≈ $7.03 Million |
AU$-1.88 Million ≈ $-1.33 Million |
-0.189x | +59.38% |
| 2006-06-30 | AU$10.31 Million ≈ $7.30 Million |
AU$-4.81 Million ≈ $-3.40 Million |
-0.466x | -56.00% |
| 2005-06-30 | AU$13.38 Million ≈ $9.47 Million |
AU$-4.00 Million ≈ $-2.83 Million |
-0.299x | +24.81% |
| 2004-06-30 | AU$12.90 Million ≈ $9.13 Million |
AU$-5.13 Million ≈ $-3.63 Million |
-0.398x | -1838.78% |
| 2003-06-30 | AU$16.18 Million ≈ $11.45 Million |
AU$-331.95K ≈ $-234.87K |
-0.021x | -132.24% |
| 2002-06-30 | AU$19.60 Million ≈ $13.87 Million |
AU$1.25 Million ≈ $882.24K |
0.064x | +120.59% |
| 2001-06-30 | AU$13.18 Million ≈ $9.33 Million |
AU$-4.07 Million ≈ $-2.88 Million |
-0.309x | -- |
About Optiscan Imaging Ltd
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows;… Read more